SiteOne Therapeutics Awarded up to $15M Grant to Develop NaV1.8 Inhibitor
18 May 2023 //
PR NEWSWIRE
SiteOne Tx Collaborates with Vertex Pharma to Advance NaV1.7 Inhibitors for Pain
19 Jan 2022 //
PRNEWSWIRE
18 May 2023 //
PR NEWSWIRE
19 Jan 2022 //
PRNEWSWIRE